Marta COSCIA

Assistant Professor of Hematology

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marta Coscia is an Assistant Professor of Hematology at the University of Turin, Italy. Her research focuses on chronic lymphocytic leukemia (CLL), with recent studies exploring treatment outcomes, immune responses to vaccination, and prognostic factors in patients. She has contributed significantly to understanding the clinical implications of new and existing therapies in hematologic malignancies, particularly relating to real-world evidence and patient management strategies.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (18)

Luca Laurenti

Università Cattolica del Sacro Cuore

ITALY

Marta COSCIA

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study

Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites—A Retrospective Clinico-Pathological Study of 35 Cases

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study

CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL

Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy

Collaborators (18)

Luca Laurenti

Carmen Mannucci

Gian Matteo Rigolin

Francesca Romana Mauro

G. Gentile

Antonio Cuneo

Stefano Molica

PAOLO SPORTOLETTI

Claudia Voena

Joanna Kopecka

Roberto Marasca

Donato Mannina

Candida VITALE

Gianluca GAIDANO

Roberto CARONNA

Ilaria DEL GIUDICE

Andrea Visentin

Livio Trentin

Make your next move.